EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications

Yuyue Qiu, Xiaoni Shao

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s524008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yuyue Qiu und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Food, Southwest Minzu University, Chengdu, Sichuan, 610225, People's Republic of China. Hauptthemen laut MEDLINE: Medicine, Chinese Traditional, Histones, Drugs, Chinese Herbal, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone lactylation, as a common post-translational modification (PTM), is crucial in diseases. Aberrant histone lactylation has been linked to disease pathogenesis, thus positioning it as a therapeutic target. This review summarizes the bidirectional relationship between histone lactylation and diseases, emphasizing how Traditional Chinese medicine (TCM) regulates lactate levels to restore histone lactylation homeostasis. Mechanistically, TCM modulates histone lactylation through dual regulation of lactyltransferases and lactate metabolism, thereby influencing disease progression in inflammatory, metabolic, and neoplastic disorders. Notably, TCM is characterized by unique advantages of cost-effectiveness, high efficacy, and minimal adverse effects. For diseases with established drug resistance, TCM offers a promising therapeutic alternative in managing drug-resistant illness by regulating histone lactylation. This review is conducive to understanding the relationship between histone lactylation and disease. TCM effectively treats diseases through the regulation of histone lactylation, thereby highlighting its potential for disease treatment application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicine, Chinese TraditionalHistonesDrugs, Chinese HerbalNeoplasmsHumansAnimalsProtein Processing, Post-TranslationalInflammation

Stichwörter der Autor:innen

Traditional Chinese medicinediseasehistone lactylationmechanismtherapeutic target

Substanzen

HistonesDrugs, Chinese Herbal

Autor:innen und Institutionen

  • College of Pharmacy and Food, Southwest Minzu University, Chengdu, Sichuan, 610225, People's Republic of China.

Zitieren

APA

Qiu, Y., & Shao, X. (2025). Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s524008

Vancouver

Qiu Y, Shao X. Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s524008

BibTeX
@article{Qiu2025,
  author = {Qiu, Yuyue and Shao, Xiaoni},
  title = {Histone Lactylation in Diseases: Regulation by Traditional Chinese Medicine and Therapeutic Implications},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s524008}
}
Kostenlos starten →